Eric Richman

Labconnect LLC provides global central laboratory services. It offers routine and esoteric laboratory testing, kit building, sample management, biorepository and scientific support services. The company serves biopharmaceutical, medical device and contract research organizations. Labconnect was founded by Jeff Mayhew in 2002 and is headquartered in Seattle, WA.

Labconnect Holdings, Inc. engages in providing laboratory services which include routine and esoteric laboratory testing, kit building, sample management, biorepository and scientific support services for biopharmaceutical. The company is headquartered in Seattle, WA.

LabConnect, Inc. provides central laboratory support services. The company is based in Johnson City, TN and has subsidiaries in Netherlands. The company was founded in 2002. Dawn Gail Sherman has been the CEO of the company since 2022.

Verimmune, Inc. is a company based in Washington that is dedicated to developing a first-in-class cancer immunotherapy called anti-tumor immune redirection (AIR). Verimmune's proprietary virus-inspired particle (VIP) technology platform redirects pre-existing pathogenic or childhood vaccine immune memory toward tumors. The American company's lead immuno-oncology product candidate, Veri-101, harnesses the cellular immune memory responses from prior cytomegalovirus (CMV) infection to fight cancer. This mechanism of action has the potential to redefine the treatment paradigm for patients with untreatable cancers or resistance to existing therapies. The company was founded in 1995 by John Troyer and Joshua Weiyuan Wang, with Joshua Weiyuan Wang serving as the CEO since then.

Labconnect LLC provides global central laboratory services. It offers routine and esoteric laboratory testing, kit building, sample management, biorepository and scientific support services. The company serves biopharmaceutical, medical device and contract research organizations. Labconnect was founded by Jeff Mayhew in 2002 and is headquartered in Seattle, WA.

Labconnect LLC provides global central laboratory services. It offers routine and esoteric laboratory testing, kit building, sample management, biorepository and scientific support services. The company serves biopharmaceutical, medical device and contract research organizations. Labconnect was founded by Jeff Mayhew in 2002 and is headquartered in Seattle, WA.

Labconnect LLC provides global central laboratory services. It offers routine and esoteric laboratory testing, kit building, sample management, biorepository and scientific support services. The company serves biopharmaceutical, medical device and contract research organizations. Labconnect was founded by Jeff Mayhew in 2002 and is headquartered in Seattle, WA.

LabConnect, Inc. provides central laboratory support services. The company is based in Johnson City, TN and has subsidiaries in Netherlands. The company was founded in 2002. Dawn Gail Sherman has been the CEO of the company since 2022.

InFUSE Holdings, Inc. owns and operates ambulatory infusion centers. The company was founded by Timothy P. Johnson, Eric I. Richman, David M. Rothenberg, Gregory Gottschlich and is headquartered in Bethesda, MD.

LabConnect, Inc. provides central laboratory support services. The company is based in Johnson City, TN and has subsidiaries in Netherlands. The company was founded in 2002. Dawn Gail Sherman has been the CEO of the company since 2022.

Verimmune, Inc. is a company based in Washington that is dedicated to developing a first-in-class cancer immunotherapy called anti-tumor immune redirection (AIR). Verimmune's proprietary virus-inspired particle (VIP) technology platform redirects pre-existing pathogenic or childhood vaccine immune memory toward tumors. The American company's lead immuno-oncology product candidate, Veri-101, harnesses the cellular immune memory responses from prior cytomegalovirus (CMV) infection to fight cancer. This mechanism of action has the potential to redefine the treatment paradigm for patients with untreatable cancers or resistance to existing therapies. The company was founded in 1995 by John Troyer and Joshua Weiyuan Wang, with Joshua Weiyuan Wang serving as the CEO since then.

PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD.

Verimmune, Inc. is a company based in Washington that is dedicated to developing a first-in-class cancer immunotherapy called anti-tumor immune redirection (AIR). Verimmune's proprietary virus-inspired particle (VIP) technology platform redirects pre-existing pathogenic or childhood vaccine immune memory toward tumors. The American company's lead immuno-oncology product candidate, Veri-101, harnesses the cellular immune memory responses from prior cytomegalovirus (CMV) infection to fight cancer. This mechanism of action has the potential to redefine the treatment paradigm for patients with untreatable cancers or resistance to existing therapies. The company was founded in 1995 by John Troyer and Joshua Weiyuan Wang, with Joshua Weiyuan Wang serving as the CEO since then.

Labconnect LLC provides global central laboratory services. It offers routine and esoteric laboratory testing, kit building, sample management, biorepository and scientific support services. The company serves biopharmaceutical, medical device and contract research organizations. Labconnect was founded by Jeff Mayhew in 2002 and is headquartered in Seattle, WA.

Labconnect Holdings, Inc. engages in providing laboratory services which include routine and esoteric laboratory testing, kit building, sample management, biorepository and scientific support services for biopharmaceutical. The company is headquartered in Seattle, WA.

InFUSE Holdings, Inc. owns and operates ambulatory infusion centers. The company was founded by Timothy P. Johnson, Eric I. Richman, David M. Rothenberg, Gregory Gottschlich and is headquartered in Bethesda, MD.

Verimmune, Inc. is a company based in Washington that is dedicated to developing a first-in-class cancer immunotherapy called anti-tumor immune redirection (AIR). Verimmune's proprietary virus-inspired particle (VIP) technology platform redirects pre-existing pathogenic or childhood vaccine immune memory toward tumors. The American company's lead immuno-oncology product candidate, Veri-101, harnesses the cellular immune memory responses from prior cytomegalovirus (CMV) infection to fight cancer. This mechanism of action has the potential to redefine the treatment paradigm for patients with untreatable cancers or resistance to existing therapies. The company was founded in 1995 by John Troyer and Joshua Weiyuan Wang, with Joshua Weiyuan Wang serving as the CEO since then.

LabConnect, Inc. provides central laboratory support services. The company is based in Johnson City, TN and has subsidiaries in Netherlands. The company was founded in 2002. Dawn Gail Sherman has been the CEO of the company since 2022.

Verimmune, Inc. is a company based in Washington that is dedicated to developing a first-in-class cancer immunotherapy called anti-tumor immune redirection (AIR). Verimmune's proprietary virus-inspired particle (VIP) technology platform redirects pre-existing pathogenic or childhood vaccine immune memory toward tumors. The American company's lead immuno-oncology product candidate, Veri-101, harnesses the cellular immune memory responses from prior cytomegalovirus (CMV) infection to fight cancer. This mechanism of action has the potential to redefine the treatment paradigm for patients with untreatable cancers or resistance to existing therapies. The company was founded in 1995 by John Troyer and Joshua Weiyuan Wang, with Joshua Weiyuan Wang serving as the CEO since then.

Labconnect LLC provides global central laboratory services. It offers routine and esoteric laboratory testing, kit building, sample management, biorepository and scientific support services. The company serves biopharmaceutical, medical device and contract research organizations. Labconnect was founded by Jeff Mayhew in 2002 and is headquartered in Seattle, WA.

Labconnect Holdings, Inc. engages in providing laboratory services which include routine and esoteric laboratory testing, kit building, sample management, biorepository and scientific support services for biopharmaceutical. The company is headquartered in Seattle, WA.

Labconnect LLC provides global central laboratory services. It offers routine and esoteric laboratory testing, kit building, sample management, biorepository and scientific support services. The company serves biopharmaceutical, medical device and contract research organizations. Labconnect was founded by Jeff Mayhew in 2002 and is headquartered in Seattle, WA.

Labconnect LLC provides global central laboratory services. It offers routine and esoteric laboratory testing, kit building, sample management, biorepository and scientific support services. The company serves biopharmaceutical, medical device and contract research organizations. Labconnect was founded by Jeff Mayhew in 2002 and is headquartered in Seattle, WA.

Labconnect LLC provides global central laboratory services. It offers routine and esoteric laboratory testing, kit building, sample management, biorepository and scientific support services. The company serves biopharmaceutical, medical device and contract research organizations. Labconnect was founded by Jeff Mayhew in 2002 and is headquartered in Seattle, WA.

Verimmune, Inc. is a company based in Washington that is dedicated to developing a first-in-class cancer immunotherapy called anti-tumor immune redirection (AIR). Verimmune's proprietary virus-inspired particle (VIP) technology platform redirects pre-existing pathogenic or childhood vaccine immune memory toward tumors. The American company's lead immuno-oncology product candidate, Veri-101, harnesses the cellular immune memory responses from prior cytomegalovirus (CMV) infection to fight cancer. This mechanism of action has the potential to redefine the treatment paradigm for patients with untreatable cancers or resistance to existing therapies. The company was founded in 1995 by John Troyer and Joshua Weiyuan Wang, with Joshua Weiyuan Wang serving as the CEO since then.

ADMA Plasma Biologics, Inc. develops medicines for the treatment of infectious diseases. The company was founded in 2007 and is headquartered in Hackensack, NJ.

ADMA Plasma Biologics, Inc. develops medicines for the treatment of infectious diseases. The company was founded in 2007 and is headquartered in Hackensack, NJ.

ADMA Plasma Biologics, Inc. develops medicines for the treatment of infectious diseases. The company was founded in 2007 and is headquartered in Hackensack, NJ.

Labconnect LLC provides global central laboratory services. It offers routine and esoteric laboratory testing, kit building, sample management, biorepository and scientific support services. The company serves biopharmaceutical, medical device and contract research organizations. Labconnect was founded by Jeff Mayhew in 2002 and is headquartered in Seattle, WA.

Lev Pharmaceuticals, Inc. develops and commercializes therapeutic products for the treatment of inflammatory diseases. It researches a series of drugs to fight both edema and heart attacks. The company is located in New York.

ZyVersa Therapeutics Operating, Inc. operates as a specialty pharmaceutical company, which develops and commercializes prescription pharmaceutical products. The firm focuses on developing products for the treatment of men?s health, as well as for other markets where current therapies are suboptimal and underdeveloped. It offers VAR 100, an oral formulation of native testosterone to treat male hypogonadism; and VAR 200 that minimizes and prevents kidney cell damage, and improves focal segmental glomerulosclerosis prognosis. The company was founded by Stephen C. Glover and Shawn M. Titcomb in 2014 and is headquartered in Weston, FL.